Cargando…
1712. Reduction of Neonatal Methicillin-Susceptible Staphylococcus aureus Bloodstream Infections After Implementation of a S. aureus Screening and Decolonization Protocol
BACKGROUND: Staphylococcus aureus (SA) is an endemic, clinically important organism in Neonatal Intensive Care Units (NICUs). An 86-bed level III NICU at an academic medical center saw an increase in patients with methicillin-susceptible SA (MSSA) bloodstream infections (BSIs) from October-December...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10677472/ http://dx.doi.org/10.1093/ofid/ofad500.1545 |
_version_ | 1785150138055917568 |
---|---|
author | Weber, Rachel Wharry, Jeananne Malczynski, Michael Lehman, Jennifer Caldarelli, Leslie Bolon, Maureen K |
author_facet | Weber, Rachel Wharry, Jeananne Malczynski, Michael Lehman, Jennifer Caldarelli, Leslie Bolon, Maureen K |
author_sort | Weber, Rachel |
collection | PubMed |
description | BACKGROUND: Staphylococcus aureus (SA) is an endemic, clinically important organism in Neonatal Intensive Care Units (NICUs). An 86-bed level III NICU at an academic medical center saw an increase in patients with methicillin-susceptible SA (MSSA) bloodstream infections (BSIs) from October-December 2020, as well as a cluster of patients with MSSA skin infections associated with intravenous catheters, which led to the intervention described. METHODS: We created a multidisciplinary team and reviewed infection prevention measures in our NICU, national recommendations and published literature. Previous state, NICU patients were screened for methicillin-resistant SA (MRSA) on day of life 7 or upon admission from an outside hospital or home. On 11/1/2021, we implemented weekly screening cultures for MRSA and MSSA among all NICU patients, performed using a composite swab of the bilateral anterior nares, axilla, peri-umbilical area, and perianal area. Decolonization of SA-colonized patients was performed with mupirocin (MUP) and chlorhexidine gluconate (CHG) bathing. MUP was applied to nares twice per day for 5 days for all colonized patients and 5 days of CHG bathing was administered only to patients greater than 48 weeks postmenstrual age. Patients were decolonized up to 2 times. Incidence rates (IR) and incidence rate ratios (IRR) were calculated. RESULTS: Between 11/1/2021 – 1/30/23, 1186 unique patients were screened with 177 unique patients colonized with MSSA and 9 unique patients colonized with MRSA. Of those colonized with MSSA, 126 (71.2%) patients were treated, with 123/126 treated with MUP only and 3/126 treated with MUP and CHG. Table 1 describes SA outcomes in the 15 month pre- and post-intervention periods. In the post-intervention period we observed a 73% decrease in MSSA BSIs (IRR, 0.27, 95% CI (0.05, 1.03)). [Figure: see text] CONCLUSION: Implementation of a SA screening and decolonization protocol in our NICU resulted in a statistically non-significant decrease in MSSA BSIs. Future work will seek to identify risk factors for colonization, factors associated with successful decolonization and genomic sequencing of MSSA isolates to characterize the spread of MSSA among neonates. DISCLOSURES: All Authors: No reported disclosures |
format | Online Article Text |
id | pubmed-10677472 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-106774722023-11-27 1712. Reduction of Neonatal Methicillin-Susceptible Staphylococcus aureus Bloodstream Infections After Implementation of a S. aureus Screening and Decolonization Protocol Weber, Rachel Wharry, Jeananne Malczynski, Michael Lehman, Jennifer Caldarelli, Leslie Bolon, Maureen K Open Forum Infect Dis Abstract BACKGROUND: Staphylococcus aureus (SA) is an endemic, clinically important organism in Neonatal Intensive Care Units (NICUs). An 86-bed level III NICU at an academic medical center saw an increase in patients with methicillin-susceptible SA (MSSA) bloodstream infections (BSIs) from October-December 2020, as well as a cluster of patients with MSSA skin infections associated with intravenous catheters, which led to the intervention described. METHODS: We created a multidisciplinary team and reviewed infection prevention measures in our NICU, national recommendations and published literature. Previous state, NICU patients were screened for methicillin-resistant SA (MRSA) on day of life 7 or upon admission from an outside hospital or home. On 11/1/2021, we implemented weekly screening cultures for MRSA and MSSA among all NICU patients, performed using a composite swab of the bilateral anterior nares, axilla, peri-umbilical area, and perianal area. Decolonization of SA-colonized patients was performed with mupirocin (MUP) and chlorhexidine gluconate (CHG) bathing. MUP was applied to nares twice per day for 5 days for all colonized patients and 5 days of CHG bathing was administered only to patients greater than 48 weeks postmenstrual age. Patients were decolonized up to 2 times. Incidence rates (IR) and incidence rate ratios (IRR) were calculated. RESULTS: Between 11/1/2021 – 1/30/23, 1186 unique patients were screened with 177 unique patients colonized with MSSA and 9 unique patients colonized with MRSA. Of those colonized with MSSA, 126 (71.2%) patients were treated, with 123/126 treated with MUP only and 3/126 treated with MUP and CHG. Table 1 describes SA outcomes in the 15 month pre- and post-intervention periods. In the post-intervention period we observed a 73% decrease in MSSA BSIs (IRR, 0.27, 95% CI (0.05, 1.03)). [Figure: see text] CONCLUSION: Implementation of a SA screening and decolonization protocol in our NICU resulted in a statistically non-significant decrease in MSSA BSIs. Future work will seek to identify risk factors for colonization, factors associated with successful decolonization and genomic sequencing of MSSA isolates to characterize the spread of MSSA among neonates. DISCLOSURES: All Authors: No reported disclosures Oxford University Press 2023-11-27 /pmc/articles/PMC10677472/ http://dx.doi.org/10.1093/ofid/ofad500.1545 Text en © The Author(s) 2023. Published by Oxford University Press on behalf of Infectious Diseases Society of America. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Abstract Weber, Rachel Wharry, Jeananne Malczynski, Michael Lehman, Jennifer Caldarelli, Leslie Bolon, Maureen K 1712. Reduction of Neonatal Methicillin-Susceptible Staphylococcus aureus Bloodstream Infections After Implementation of a S. aureus Screening and Decolonization Protocol |
title | 1712. Reduction of Neonatal Methicillin-Susceptible Staphylococcus aureus Bloodstream Infections After Implementation of a S. aureus Screening and Decolonization Protocol |
title_full | 1712. Reduction of Neonatal Methicillin-Susceptible Staphylococcus aureus Bloodstream Infections After Implementation of a S. aureus Screening and Decolonization Protocol |
title_fullStr | 1712. Reduction of Neonatal Methicillin-Susceptible Staphylococcus aureus Bloodstream Infections After Implementation of a S. aureus Screening and Decolonization Protocol |
title_full_unstemmed | 1712. Reduction of Neonatal Methicillin-Susceptible Staphylococcus aureus Bloodstream Infections After Implementation of a S. aureus Screening and Decolonization Protocol |
title_short | 1712. Reduction of Neonatal Methicillin-Susceptible Staphylococcus aureus Bloodstream Infections After Implementation of a S. aureus Screening and Decolonization Protocol |
title_sort | 1712. reduction of neonatal methicillin-susceptible staphylococcus aureus bloodstream infections after implementation of a s. aureus screening and decolonization protocol |
topic | Abstract |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10677472/ http://dx.doi.org/10.1093/ofid/ofad500.1545 |
work_keys_str_mv | AT weberrachel 1712reductionofneonatalmethicillinsusceptiblestaphylococcusaureusbloodstreaminfectionsafterimplementationofasaureusscreeninganddecolonizationprotocol AT wharryjeananne 1712reductionofneonatalmethicillinsusceptiblestaphylococcusaureusbloodstreaminfectionsafterimplementationofasaureusscreeninganddecolonizationprotocol AT malczynskimichael 1712reductionofneonatalmethicillinsusceptiblestaphylococcusaureusbloodstreaminfectionsafterimplementationofasaureusscreeninganddecolonizationprotocol AT lehmanjennifer 1712reductionofneonatalmethicillinsusceptiblestaphylococcusaureusbloodstreaminfectionsafterimplementationofasaureusscreeninganddecolonizationprotocol AT caldarellileslie 1712reductionofneonatalmethicillinsusceptiblestaphylococcusaureusbloodstreaminfectionsafterimplementationofasaureusscreeninganddecolonizationprotocol AT bolonmaureenk 1712reductionofneonatalmethicillinsusceptiblestaphylococcusaureusbloodstreaminfectionsafterimplementationofasaureusscreeninganddecolonizationprotocol |